首页 | 本学科首页   官方微博 | 高级检索  
检索        

血浆同型半胱氨酸对慢性心力衰竭患者的作用及意义
引用本文:刘沙沙,田 祥,李 放,邸书华,齐 强,王 伟,耿 巍.血浆同型半胱氨酸对慢性心力衰竭患者的作用及意义[J].临床荟萃,2016,31(6):658.
作者姓名:刘沙沙  田 祥  李 放  邸书华  齐 强  王 伟  耿 巍
作者单位:1.承德医学院,河北 承德067000;2.保定市第一中心医院 心内科,河北 保定 071000
摘    要:目的 通过观察慢性心力衰竭患者血同型半胱氨酸(Hcy)与B型利钠肽(BNP)的相关性,进一步探讨 测定血Hcy水平对于慢性心力衰竭患者的作用及意义。方法 入选了151例慢性心力衰竭患者作为心力衰竭组,其 中男93例,女58例,年龄27~92岁,平均(66.7±11.6)岁,所有入选患者均抽取空腹肘静脉血,测定血Hcy水平、 BNP浓度、血脂、血糖等。同时入选同期住院的249例心功能正常的患者作为对照组。结果 ①心力衰竭组的血 Hcy水平明显高于对照组(19.90±5.07)μmol/Lvs(14.84±4.87)μmol/L(P <0.01);心力衰竭组的血BNP浓度 明显高于对照组(1851.67±742.59)ng/Lvs(197.52±84.46)ng/L(P <0.01);②血Hcy、BNP随心功能分级的增 加而增加,差异有统计学意义(P <0.01);③血Hcy与BNP呈显著正相关(r =0.629,P <0.01);④Logistic回归分 析显示:高血压(OR =1.826,95%CI =1.021~3.266,P <0.05)、糖尿病(OR =1.716,95%CI =1.020~2.887, P <0.05)、高脂血症(OR =1.856,95%CI =1.015~3.396,P <0.05)、吸烟(OR =1.952,95%CI =1.233~ 3.089,P <0.05)、Hcy(OR =3.743,95%CI =2.271~6.169,P <0.01)为慢性心力衰竭患者的危险因素;⑤血 Hcy诊断慢性心力衰竭的ROC 曲线参数分析显示:AUC 为0.754,95%CI =0.706~0.802,P <0.01,临界值为 17.75μmo/L,敏感度为66.20%,特异度为73.90%。结论 血Hcy为慢性心力衰竭患者的独立危险因素,且临界值, 可作为慢性心力衰竭的新的诊断指标。

关 键 词:心力衰竭  半胱氨酸  利钠肽    心功能  
收稿时间:2016-02-17

Effect and significance of plasma homocysteine in patients with chronic heart failure
Liu Shasha,Tian Xiang,Li Fang,Di Shuhua,Qi Qiang,Wang Wei,Geng Wei.Effect and significance of plasma homocysteine in patients with chronic heart failure[J].Clinical Focus,2016,31(6):658.
Authors:Liu Shasha  Tian Xiang  Li Fang  Di Shuhua  Qi Qiang  Wang Wei  Geng Wei
Institution:1.Chengde Medical University,Chengde 067000,China;; 2.Department of Cardiology, the First  Central Hospital, Baoding  071000, China;
Abstract:ObjectiveTo investigate the role of plasma homocysteine and its clinical significance in chronic heart failure patients by observing the relationship of plasma homocysteine (Hcy) and B type natriuretic peptide (BNP).MethodsA total of 151 chronic heart failure patients including 93 males and 58 females, average age (66.7±11.6) years were investigated,and 249 patients with normal cardiac function at the same time of hospitalization served as control group.Plasma Hcy, BNP,lipids, blood glucose were studied.Results①The plasma Hcy concentration in heart failure patients was significantly higher than control group (19.90±5.07) μmol/L vs (14.84±4.87) μmol/L(P<0.01);The serum BNP concentration in heart failure patients was significantly higher than control group (1 851.67±742.59) ng/L vs (197.5±84.5) ng/L(P<0.01). ② The plasma Hcy and BNP were different from New York Heart Association (NYHA) classes (P<0.01). ③ The plasma Hcy and BNP were linear positive correlation (r=0.629,P<0.01). ④The results of logistic regression showed that hypertension (OR=1.826,95%CI=1.021 3.266,P<0.05),diabetes (OR=1.716,95%CI=1.020 2.887,P<0.05),hyperlipidemia (OR=1.856,95%CI=1.015 3.396,P<0.05),smoking (OR=1.952,95%CI=1.233 3.089,P<0.05),Hcy(OR=3.743,95%CI=2.271 6.169,P<0.01) were risk factors for patients with chronic heart failure.⑤Receiver operating characteristic curve analysis indicated the cut off of Hcy for chronic heart failure was 17.75 μmo/L (ROC area under curve: 0.754,95%CI=0.706 0.802,P<0.01) with 73.90% specificity and 66.20% sensitivity.ConclusionHcy is an independent risk factor for chronic heart failure, and the cut of value can be used as a new diagnostic index for chronic heart failure.
Keywords:heart failure  cysteine  natriuretic   peptide  brain  cardiac function  
本文献已被 CNKI 等数据库收录!
点击此处可从《临床荟萃》浏览原始摘要信息
点击此处可从《临床荟萃》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号